GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diagnos Inc (OTCPK:DGNOF) » Definitions » ROE % Adjusted to Book Value

Diagnos (Diagnos) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Diagnos ROE % Adjusted to Book Value?

Diagnos's ROE % for the quarter that ended in Dec. 2023 was 0.00%. Diagnos's PB Ratio for the quarter that ended in Dec. 2023 was N/A. Diagnos's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was N/A.


Diagnos ROE % Adjusted to Book Value Historical Data

The historical data trend for Diagnos's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnos ROE % Adjusted to Book Value Chart

Diagnos Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -4.64 - -

Diagnos Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Diagnos's ROE % Adjusted to Book Value

For the Health Information Services subindustry, Diagnos's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diagnos's ROE % Adjusted to Book Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Diagnos's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Diagnos's ROE % Adjusted to Book Value falls into.



Diagnos ROE % Adjusted to Book Value Calculation

Diagnos's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Diagnos's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diagnos ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Diagnos's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Diagnos (Diagnos) Business Description

Traded in Other Exchanges
Address
7005 Taschereau Boulevard, Suite 265, Brossard, Longueuil, QC, CAN, J4Z 1A7
Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy. The company provides image analysis services through CARA (Computer Assisted Retinal Analysis). It operates in the business segment of Healthcare services. The company has a business presence in Canada, the United States, UAE, Saudi Arabia, Mexico, Costa Rica, and others. The company's key revenue is derived from Canada.